Diode Laser Treatment of Bladder Tumors
Diode Laser Treatment of Pta Low Grade Bladder Tumors in the Outpatient Department.
1 other identifier
interventional
21
1 country
1
Brief Summary
Laser treatment of pTa low grade bladder tumours in the outpatient department Number of Subjects/Centres Planned: 20 patients will be included in this study. The study will be performed at Department of Urology, Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark. Primary Objective: To show that small pTa bladder tumours safely can be removed with diode laser in an outpatient department Secondary Objective: To evaluate the patients experience with the laser treatment using QOL questionaires (symptom evaluation) and Visual Analog Scale Score (pain evaluation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 21, 2015
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedMay 31, 2017
May 1, 2017
1.3 years
December 21, 2015
May 30, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Tumour clearance
No bladder tumor tissue in biopsies obtained from areas where a bladder tumor one month earlier has been removed by use of diode laser.
1 month
Study Arms (1)
Laser treatment
OTHERIntervention is diode laser treatment of bladder cancer through a cystoscope without sedation of the patient.
Interventions
Intervention is diode laser treatment of bladder cancer through a cystoscope in the outpatient department
Eligibility Criteria
You may qualify if:
- Recurrence of pTa low grade urothelial bladder tumor
- Tumor \< 1.5 cm
- \< 6 tumors
You may not qualify if:
- Patients with porphyria
- Known hypersensitivity to Hexvix® or porphyrins
- Use of any anticoagulants
- Macroscopic hematuria
- Pregnant or breast feeding women
- Expected poor compliance
- Patients \< 18 years
- Patients who do not read or understand Danish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urological department, Frederiksberg Hospital
Copenhagen, 2000, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregers G Hermann, MD
Dept Urology, Herlev/Gentofte hospital, Copenhagen, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- consultant urologist
Study Record Dates
First Submitted
December 21, 2015
First Posted
April 14, 2016
Study Start
November 1, 2015
Primary Completion
February 1, 2017
Study Completion
March 1, 2017
Last Updated
May 31, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share